Delivered as a Hybrid Event
Japan
Delivered as a Hybrid Event
Asia's leading conference to accelerate antibody/protein therapeutics, ADCs, Bispecifics & Immuno-oncology
Bringing together the antibody/protein therapeutic community to share advances in antibody discovery & engineering, bi/multispecific antibodies, ADCs, immuno-oncology & AI/ML-enabled applications
Select the right antibody, move faster towards IND, and apply clinical learnings from real-world case studies.
This year we brought you:
+
Antibody Experts
+
Leading Speakers
+
Hours of Scientific Content
Hours
of Networking
REGISTER YOUR INTEREST, HAVE YOUR SAY, GET AN EXCLUSIVE DISCOUNT!
Would you like to speak at the 2025 event? Have you got topics or speakers in mind that you would like us to bring to Japan? Or, do you simply just want to be the first to get the updates on the programme?
Have your say in shaping the agenda for the return of Antibody Engineering & Therapeutics Asia 2025, or register your interest so you don't miss any updates, by completing the form below. Plus, by registering via the form you will get early-access to the agenda - as well as a discount on your pass!
Asia's leading Antibody Engineering & Therapeutics conference
What to expect?
Join industry pioneers as they explore the latest breakthroughs in the antibody community and dive into:
- Bispecific and Multispecific Antibodies
- Antibodies for Novel/Challenging Targets
- Immune Cell Engager Antibody Technologies
- Antibody-Drug Conjugates
- Disease-Area Specific Antibodies
- AI/Machine Learning for Antibody Developability
- New Binders, Therapeutic Modalities & Antibody Formats
- Agonist Antibodies and Conditional Antibodies
- Novel Antibody Technologies and Applications
- Preclinical and Clinical Antibody Case Studies
Plus, enhance your experience with two workshop add-ons:
- Introduction to Antibody Engineering (AM)
- Introduction to Bioconjugates and ADCs (PM)
Who will you meet?
Dedicated to connect you with 200+ leaders including:
- Renowned industry and academic scientists specializing in antibody and protein engineering.
- Experts in therapeutic development sharing the latest preclinical and clinical data on antibodies, ADCs, bispecifics, and immuno-oncology programs.
- Innovators presenting cutting-edge advances in antibody-related technologies from around the world.
- Potential partners to help accelerate your next-generation antibodies towards commercial success.
33+ expert speakers
Hear from the leading companies in the industry including Chugai Pharmaceutical Co., Ltd., Gilead Sciences, Numab Therapeutics, Genmab, Daiichi, Adimab and Roche.
Prepare to be inspired by our top-tier keynote speaker: Tomoyuki Igawa from Chugai Pharmaceutical Co., Ltd.
Gain in-depth insights from the leading minds in antibody and protein therapeutics. Discover the latest advancements in antibody discovery, engineering, bispecifics, ADCs, and immuno-oncology, including AI/ML applications.
Leave with confidence to select the right antibodies, accelerate your path to IND, and apply clinical insights from real-world case studies to drive your success.
Connect with key buyers at Antibody Asia 2025 in Japan
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Blake Shuka to find out you can get involved:
BShuka@informaconnectls.com | (+1) 212-600-3451